deltatrials

King Abdullah International Medical Research Center Clinical Trials

Sponsors / King Abdullah International Medical Research Center

According to ClinicalTrials.gov, King Abdullah International Medical Research Center has served as lead sponsor on 36 registered trials. 4 trials are actively recruiting participants, 0 remain active without open enrollment, and 17 have concluded. 3 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. The cumulative planned enrollment figure across all listed trials is 49,275 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.

36
Total Trials
4
Recruiting
0
Other Active
17
Completed
3
Terminated / Withdrawn
49,275
Total Enrollment

Termination reasons: Recruitment67% · Safety33%

Recent Terminations

  • NCT06627166 Stopped Jun 2022
    Severe Acute Respiratory Infection
    "Due to recruitment failure"
  • NCT03189667 Phase NA Stopped Feb 2019
    Dysfunctional Dialysis Arteriovenous Fistula
    "slow recruitment and recent concerns of safety of Paclitaxel coated balloons and associated increased risk death"
  • NCT02086487 Phase PHASE4 Stopped Aug 2016
    Myeloid Leukemia, Chronic
    "Because of many unseen obstacles resulted in poor accrual, study is terminated."

Active Trials (0 total)

Top Conditions

Top Locations